Lyka Labs Shares Soar 7% on CDSCO Approval for Drug
Shares of Lyka Labs Ltd soared 7% and hit an intraday high of Rs 160 on 15 October after the company announced that they have...
Tag : Central Drugs Standard Control Organisation (CDSCO)
Torrent Pharma Refutes Claims Made By CDSCO for Shelcal 500, Shares Gain
Torrent Pharmaceuticals shares were trading in the green on 27 September after the company refuted claims that one of its products failed a quality test. ...
AstraZeneca Pharma Shares Surge 12% After Approval to Launch Cancer Drug in India
Shares of AstraZeneca Pharma India Ltd. rallied 12%, reaching a day’s high of Rs 7,598 on 24th September, after the company announced that it had...
Sanofi Secures CDSCO Approval for Beyfortus India
Sanofi India announced that it has received marketing authorisation from the Central Drugs Standard Control Organisation (CDSCO) for Beyfortus. Beyfortus is intended to prevent Respiratory...
Shilpa Medicare Rise on Introduces Drugs of Breast Cancer
Shares of Shilpa Medicare rose 3.31% to Rs 291.55 after the drugmaker launched capecitabine (Capebel) dispersible tablets (DT), a technology that disperses faster in 90...
Laurus Labs Receives Licence from DRDO to For Covid Drug
Laurus Labs has said it has received the license from Defence Research and Development Organisation (DRDO) to manufacture and market COVID-19 treatment drug 2-Deoxy-D-Glucose (2DG)....
Zydus Cadila Applies for Emergency Use of Covid-19 Vaccine
Indian drugmaker Zydus Cadila has applied to the Central Drugs Standard Control Organisation (CDSCO) for emergency use approval of its Covid-19 vaccine, which showed a...
Cipla Gets DGCI Permission to Import Moderna’s Vaccine
Cipla, a multinational pharmaceutical company headquartered in Mumbai, on Tuesday received approval from the Drugs Controller General of India (DCGI) to import Moderna’s coronavirus vaccine...
Government of India Shares Status of Covid-19 Vaccines
Today, the Indian government shared the status of a potential vaccine against the novel coronavirus pandemic. The government is concerning the vaccine manufacturing industry and...